DiA Imaging Analysis

Company Overview

Snapshot

Founded in October 2009 by Arnon Toussia Cohen, Noah Liel - Cohen, Hila Goldman Aslan, Hugo Guterman, and Michal Yaacobi, DiA Imaging Analysis operated with 11–50 employees. The company secured funding across 6 rounds from 14 investors, raising a total of $22.46 million. In May 2023, DiA Imaging Analysis was acquired by Philips.

Business overview

DiA Imaging Analysis provides AI-powered ultrasound analysis software designed to address challenges in image capture and accurate analysis. Its technology leverages advanced pattern recognition, deep learning, and machine learning algorithms to automatically detect image borders and identify motion, mimicking human visual analysis. The company's core product, LVivo Seamless, is an AI-based solution that preselects and analyzes optimal apical cardiac ultrasound views, generating measurements for Strain, EF, and Right Ventricle Size and Function. This reduces variability in manual view selection and visual analysis of cardiac ultrasound images. DiA's LVivo Toolbox is FDA cleared, CE marked, and ISO certified, serving thousands of end-users globally within the Health Tech & Life Sciences sector, specifically in Digital Healthcare, Medical Decision Support, and Digital Medical Diagnostics.

Strategic signal

In May 2023, DiA Imaging Analysis was acquired by Philips, a significant strategic move that validates DiA's AI-driven ultrasound technology and its potential for broader integration into global healthcare systems. This acquisition signals a strong market demand for AI solutions that enhance medical imaging diagnostics and streamline clinical workflows, positioning DiA's technology to scale under a major industry player.

Company Intelligence Q&A

What was the most significant corporate event for DiA Imaging Analysis?

In May 2023, DiA Imaging Analysis was acquired by Philips, marking a major exit for the company and integrating its AI-powered ultrasound analysis technology into a multinational healthcare corporation.

When did DiA Imaging Analysis receive FDA clearance for its cardiac ultrasound AI auto views selection?

DiA Imaging Analysis was granted FDA clearance for its cardiac ultrasound AI auto views selection in October 2020.

Which companies did DiA Imaging Analysis partner with to enhance ultrasound with AI-based image quantification?

In March 2021, DiA Imaging Analysis partnered with Philips to enhance ultrasound capabilities with AI-based image quantification.

When did DiA Imaging Analysis secure FDA clearance for new AI-powered software assisting ultrasound users to capture high-quality images?

DiA Imaging Analysis secured FDA clearance for new AI-powered software designed to assist ultrasound users in capturing high-quality images in February 2023.

What was the latest funding round for DiA Imaging Analysis?

In August 2021, DiA Imaging Analysis received funding from investors including.